Europe/India/Near East USA Asia
Bachem AG Bachem Americas, Inc. Bachem Japan K.K.
Hauptstrasse 144 3132 Kashiwa Street AREA Shinagawa, 13F
4416 Bubendorf - Switzerland Torrance, CA 90505 - USA Tokyo 108-0075 - Japan
Tel +41 58 595 2021 Tel +1 888 422 2436 Tel +81 3 4405 3141
Fax +41 58 595 2040 Tel +1 888 4BACHEM Email sales.jp@bachem.com
Email sales.ch@bachem.com Fax +1 310 539 9428  
  E-mail sales.us@bachem.com  

DETAIL

First half of 2018: Further rise in net profit; delayed sales/EBIT to be made good in second half

24. Aug 2018
  • Net income 14.9% of sales

  • EBITDA at 26.0% and EBIT at 16.2% of sales

  • Delayed sales and EBIT increase

  • Significantly stronger 2nd half anticipated

  • Annual targets confirmed

  • Outlook favorable for another very good fiscal year

     

 

 

Bubendorf/Basel, August 24, 2018 - Owing to project delays, the Bachem Group (SIX: BANB) posted a 7.2% decrease in net sales to 110.9 million CHF for the first half of 2018 (H1 2017: 119.5 million CHF). A marked increase in the second half of the year is expected to make up for this. Exchange rate movements had only a marginal impact. Sales in local currencies were 7.6% down on the first half of 2017. Sales of generics amounted to 44.1 million CHF, below the strong prior year's reference figure (52.0 million CHF). The research chemicals business unit delivered a solid performance in a challenging, highly competitive market environment. Sales of catalog products and custom synthesis products held steady at their new benchmark level. At mid-year, sales of New Chemical Entities (NCEs) were below the year-ago figure (–7.6% in local currencies) due to various delays in the clinical development of customer projects. As expected, the shift of sales to the second half described above impacted on the operating result. Operating income (EBIT) declined year-on-year by 3.4 million CHF to 18.0 million CHF in the first half of 2018. At 16.2%, the EBIT margin on the reference date likewise remained below that of the prior year period (H1 2017: 17.9%). The main causes were the higher cost base compared to the previous year and the delayed contribution margins due to project postponements. Supported by a positive foreign exchange result, net income came to 16.5 million CHF in the first half of 2018 (H1 2017: 15.8 million CHF).

 

Press Release

Half-Year Report